193 related articles for article (PubMed ID: 24069222)
1. The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study.
Dobson R; Burgess MI; Banks M; Pritchard DM; Vora J; Valle JW; Wong C; Chadwick C; George K; Keevil B; Adaway J; Ardill JE; Anthoney A; Hofmann U; Poston GJ; Cuthbertson DJ
PLoS One; 2013; 8(9):e73679. PubMed ID: 24069222
[TBL] [Abstract][Full Text] [Related]
2. Determination of the optimal echocardiographic scoring system to quantify carcinoid heart disease.
Dobson R; Cuthbertson DJ; Jones J; Valle JW; Keevil B; Chadwick C; Poston GP; Burgess MI
Neuroendocrinology; 2014; 99(2):85-93. PubMed ID: 24603343
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor.
Korse CM; Taal BG; de Groot CA; Bakker RH; Bonfrer JM
J Clin Oncol; 2009 Sep; 27(26):4293-9. PubMed ID: 19667278
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of N-terminal pro-brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease.
Bhattacharyya S; Toumpanakis C; Caplin ME; Davar J
Am J Cardiol; 2008 Oct; 102(7):938-42. PubMed ID: 18805126
[TBL] [Abstract][Full Text] [Related]
5. The role of N-terminal pro-brain natriuretic peptide, chromogranin A, and 5-hydroxyindoleacetic acid in screening for carcinoid heart disease.
Johnson KKN; Stemann Lau T; Mark Dahl Baunwall S; Elisabeth Villadsen G; Guldbrand Rasmussen V; Grønbaek H; Oksjoki RK; Dam G
J Neuroendocrinol; 2023 Oct; 35(10):e13327. PubMed ID: 37574797
[TBL] [Abstract][Full Text] [Related]
6. Activin A in carcinoid heart disease: a possible role in diagnosis and pathogenesis.
Bergestuen DS; Edvardsen T; Aakhus S; Ueland T; Oie E; Vatn M; Aukrust P; Thiis-Evensen E
Neuroendocrinology; 2010; 92(3):168-77. PubMed ID: 20720391
[TBL] [Abstract][Full Text] [Related]
7. Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality.
Dobson R; Burgess MI; Valle JW; Pritchard DM; Vora J; Wong C; Chadwick C; Keevi B; Adaway J; Hofmann U; Poston GJ; Cuthbertson DJ
Br J Cancer; 2014 Oct; 111(9):1703-9. PubMed ID: 25211656
[TBL] [Abstract][Full Text] [Related]
8. Four decades of experience with carcinoid heart disease: An analysis of 84 patients.
Levy S; Korse CE; de Groot ACA; Meijer RCA; Tesselaar MET; Valk GD
J Neuroendocrinol; 2022 Oct; 34(10):e13199. PubMed ID: 36256859
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease.
Lowenthal A; Camacho BV; Lowenthal S; Natal-Hernandez L; Liszewski W; Hills NK; Fineman JR; Bernstein HS
Am J Cardiol; 2012 Mar; 109(6):866-72. PubMed ID: 22196786
[TBL] [Abstract][Full Text] [Related]
10. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
[TBL] [Abstract][Full Text] [Related]
11. Variation in Cardiac Screening and Management of Carcinoid Heart Disease in the UK and Republic of Ireland.
Dobson R; Valle JW; Burgess MI; Poston GJ; Cuthbertson DJ
Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):741-6. PubMed ID: 26170123
[TBL] [Abstract][Full Text] [Related]
12. Serum and plasma 5-hydroxyindoleacetic acid as an alternative to 24-h urine 5-hydroxyindoleacetic acid measurement.
Adaway JE; Dobson R; Walsh J; Cuthbertson DJ; Monaghan PJ; Trainer PJ; Valle JW; Keevil BG
Ann Clin Biochem; 2016 Sep; 53(Pt 5):554-60. PubMed ID: 26438520
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide.
Jeong JH; Seo YH; Ahn JY; Kim KH; Seo JY; Kim MJ; Lee HT; Park PW
Ann Lab Med; 2016 Sep; 36(5):420-6. PubMed ID: 27374706
[TBL] [Abstract][Full Text] [Related]
14. Effect of renal failure on N-terminal Pro-Brain natriuretic peptide in patients admitted to emergency department with acute dyspnea.
Çolak A; Çuhadar S; Gölcük B; Gölcük Y; Özdoğan Ö; Çoker I
Anadolu Kardiyol Derg; 2014 Sep; 14(6):519-24. PubMed ID: 25233498
[TBL] [Abstract][Full Text] [Related]
15. Association of NT-proBNP with severity of heart valve disease in a medical patient population presenting with acute dyspnea or peripheral edema.
Behnes M; Lang S; Breithardt OA; Kaden JJ; Haghi D; Ahmad-Nejad P; Elmas E; Wolpert C; Borggrefe M; Neumaier M; Brueckmann M
J Heart Valve Dis; 2008 Sep; 17(5):557-65. PubMed ID: 18980090
[TBL] [Abstract][Full Text] [Related]
16. Comparison of N-terminal pro-atrial natriuretic peptide and three cardiac biomarkers for discriminatory ability of clinical stage in dogs with myxomatous mitral valve disease.
Ogawa M; Hori Y; Kanno N; Iwasa N; Toyofuku T; Isayama N; Yoshikawa A; Akabane R; Sakatani A; Miyakawa H; Hsu HH; Miyagawa Y; Takemura N
J Vet Med Sci; 2021 Apr; 83(4):705-715. PubMed ID: 33551383
[TBL] [Abstract][Full Text] [Related]
17. The relationship between adiponectin, NT-pro-BNP and left ventricular ejection fraction in non-cachectic patients with systolic heart failure: an observational study.
Tengiz İ; Türk UÖ; Alioğlu E; Kırılmaz B; Tamer GS; Tüzün N; Ercan E
Anadolu Kardiyol Derg; 2013 May; 13(3):221-6. PubMed ID: 23376650
[TBL] [Abstract][Full Text] [Related]
18. Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy.
Arteaga E; Araujo AQ; Buck P; Ianni BM; Rabello R; Mady C
Am Heart J; 2005 Dec; 150(6):1228-32. PubMed ID: 16338263
[TBL] [Abstract][Full Text] [Related]
19. Elevated Serotonin and NT-proBNP Levels Predict and Detect Carcinoid Heart Disease in a Large Validation Study.
Levy S; Kilgallen AB; Korse CM; Oerlemans MIFJ; Sluijter JPG; van Laake LW; Valk GD; Tesselaar MET
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35625964
[TBL] [Abstract][Full Text] [Related]
20. Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease.
Zuetenhorst JM; Korse CM; Bonfrer JM; Bakker RH; Taal BG
Br J Cancer; 2004 Jun; 90(11):2073-9. PubMed ID: 15150565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]